Go to main content

Ovarian cancers : advances through international research cooperation (GINECO, ENGOT, GCIG) / Eric Pujade-Lauraine, Isabelle Ray-Coquard, Fabrice Lécuru, editors.

Pujade-lauraine, Eric, editor.; Ray-coquard, Isabelle, editor.; Lécuru, Fabrice, editor.
2017
RC280.O8
Available Online
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS
Add to Basket

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Ovarian cancers : advances through international research cooperation (GINECO, ENGOT, GCIG) / Eric Pujade-Lauraine, Isabelle Ray-Coquard, Fabrice Lécuru, editors.
ISBN
9783319321103 (electronic book)
3319321102 (electronic book)
9783319321080
3319321080
Published
Switzerland : Springer, [2017]
Copyright
©2017
Language
English
Description
1 online resource.
Call Number
RC280.O8
Dewey Decimal Classification
616.99465
Summary
This book provides an overview of the latest developments in the concepts and management of ovarian cancer. The new data presented throughout opens the way to radically different therapeutic approaches. Surgery remains the core of ovarian cancer treatment, but its ultimate goal and the standard surgical procedure have evolved, giving rise to the question of how to label expert centers for debulking surgery. Neo-adjuvant chemotherapy is becoming more popular and is also a new field for testing novel drug combinations. Over recent years, ovarian cancer management has embraced molecular biology. It is now more correct to talk about cancers of the ovary rather than ovarian cancer, since it is not a unique disease but several entities with different molecular drivers. The significant advances in drugs targeting the microenvironment or the tumor cell DNA repair mechanisms are presented in detail together with exciting future perspectives. All these advances would not have been possible without collaborative groups such as the GINECO group in France and their integration in wider clinical research networks at the European (ENGOT) and international (GCIG) level.
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Source of Description
Description based on print version record.
Added Author
Pujade-lauraine, Eric, editor.
Ray-coquard, Isabelle, editor.
Lécuru, Fabrice, editor.
Available in Other Form
Ovarian Cancers.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Ovarian cancer management
Clinical research in Europe dedicated to ovarian cancers
Oncogenetics
Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality
How to evaluate tumor burden before therapeutic decision
Value of lymphadenectomy
HYPEC: what is the evidence?
Onco-fertility applied to ovarian cancers
First-line systemic therapy (chemo/antiangiogenics)
Elderly
Treatment at relapse (surgery & systemic treatments)
How to evaluate QoL
The future in ovarian cancers & place of the new immunotherapies in ovarian cancers
Particular types of ovarian cancers
High grade serous carcinoma & BRCA mutation anti-PARP
Borderline and low grade carcinoma
Clear Cell carcinoma
Endometrioid carcinoma
Mucinous carcinoma
Carcinosarcoma
Germ cell tumors
Sex cord tumors
Very rare ovarian malignant tumors including small cell carcinoma. Ovarian cancer management
Clinical research in Europe dedicated to ovarian cancers
Oncogenetics
Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality
How to evaluate tumor burden before therapeutic decision
Value of lymphadenectomy
HYPEC: what is the evidence?
Onco-fertility applied to ovarian cancers
First-line systemic therapy (chemo/antiangiogenics)
Elderly
Treatment at relapse (surgery & systemic treatments)
How to evaluate QoL
The future in ovarian cancers & place of the new immunotherapies in ovarian cancers
Particular types of ovarian cancers
High grade serous carcinoma & BRCA mutation anti-PARP
Borderline and low grade carcinoma
Clear Cell carcinoma
Endometrioid carcinoma
Mucinous carcinoma
Carcinosarcoma
Germ cell tumors
Sex cord tumors
Very rare ovarian malignant tumors including small cell carcinoma.

Browse Subjects

Show more subjects...

Statistics

from
to
Export